CHRISTUS Santa Rosa Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2019
NCT04125082
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

CHRISTUS Santa Rosa Cancer Center at CHRISTUS Santa Rosa Hospital - City Centre | Diabetes and Glandular Disease Clinic | Diabetes and Glandular Disease Clinic, P.A.

Active Ingredients

Drugs in Phase 4 Trials (1)

insulin human (humulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1